نتایج جستجو برای: fda criteria

تعداد نتایج: 273287  

Journal: :Annals of the rheumatic diseases 2002
D van der Heijde J Braun D McGonagle J Siegel

Emerging treatment options in ankylosing spondylitis (AS) are giving new hope to patients with this chronic and potentially disabling disease. Clinical development of new treatments requires that rigorous and well controlled trials be conducted to demonstrate safety and efficacy. A number of classification systems have been developed in recent years as a result of enhanced understanding of the ...

Journal: :Journal of pharmaceutical sciences 2012
Anita Nair Bertil Abrahamsson Dirk M Barends D W Groot Sabine Kopp James E Polli Vinod P Shah Jennifer B Dressman

The present monograph reviews data relevant to applying the biowaiver procedure for the approval of immediate release (IR) multisource solid dosage forms containing amodiaquine hydrochloride (ADQ) as the single active pharmaceutical ingredient (API). Both biopharmaceutical and clinical data of ADQ were assessed. Solubility studies revealed that ADQ meets the "highly soluble" criteria according ...

Journal: :American journal of kidney diseases : the official journal of the National Kidney Foundation 2009
Andrew S Levey Daniel Cattran Aaron Friedman W Greg Miller John Sedor Katherine Tuttle Bertram Kasiske Thomas Hostetter

Changes in proteinuria have been suggested as a surrogate outcome for kidney disease progression to facilitate the conduct of clinical trials. This report summarizes a workshop sponsored by the National Kidney Foundation and US Food and Drug Administration (FDA) with the following goals: (1) to evaluate the strengths and limitations of criteria for assessment of proteinuria as a potential surro...

Journal: :Cell structure and function 1987
S Yokota H D Fahimi

The uptake of formalin-denaturated homologous albumin (FDA) by rat liver sinus-lining cells was studied using ultrastructural, cytochemical, and immunocytochemical techniques. Three minutes after intravenous injection of: 1) FDA, 2) peroxidase-coupled FDA (HRP-FDA), 3) ferritin-labeled FDA (FE-FDA), 4) colloidal gold-labeled FDA (CG-FDA), or 5) 0.85% NaCl, livers were fixed by perfusion with tw...

Journal: :Schizophrenia bulletin 2011
Robert W Buchanan Richard S E Keefe Daniel Umbricht Michael F Green Thomas Laughren Stephen R Marder

The Food and Drug Administration (FDA)-National Institute of Mental Health (NIMH)-Measurement and Treatment Research to Improve Cognition in Schizophrenia (MATRICS) clinical trial guidelines for cognitive-enhancing drugs in schizophrenia and the MATRICS Consensus Cognitive Battery (MCCB) were designed to facilitate novel compound development in the treatment of cognitive impairments. Several st...

Journal: :Antimicrobial agents and chemotherapy 2012
Yen-Hsu Chen Po-Liang Lu Cheng-Hua Huang Chun-Hsing Liao Chin-Te Lu Yin-Ching Chuang Shih-Ming Tsao Yao-Shen Chen Yung-Ching Liu Wei-Yu Chen Tsrang-Neng Jang Hsiu-Chen Lin Chih-Ming Chen Zhi-Yuan Shi Sung-Ching Pan Jia-Ling Yang Hsiang-Chi Kung Chun-Eng Liu Yu-Jen Cheng Jien-Wei Liu Wu Sun Lih-Shinn Wang Wen-Chien Ko Kwok-Woon Yu Ping-Cherng Chiang Ming-Hsun Lee Chun-Ming Lee Gwo-Jong Hsu Po-Ren Hsueh

The Tigecycline In Vitro Surveillance in Taiwan (TIST) study, a nationwide, prospective surveillance during 2006 to 2010, collected a total of 7,793 clinical isolates, including methicillin-resistant Staphylococcus aureus (MRSA) (n = 1,834), penicillin-resistant Streptococcus pneumoniae (PRSP) (n = 423), vancomycin-resistant enterococci (VRE) (n = 219), extended-spectrum β-lactamase (ESBL)-prod...

2015
Michael Quirke Abel Wakai

Acute bacterial skin and skin structure infections (ABSSSIs), which include cellulitis, abscesses, and wound infections, are among the most commonly encountered conditions in emergency departments (EDs) internationally. Primarily, as a result of the recent epidemic of community-associated methicillin resistant Staphylococcus aureus (CA-MRSA) in North America, ED attendances and hospital admissi...

2011
Amélie van der Meersch Agnès Dechartres Philippe Ravaud

BACKGROUND Generic drugs are used by millions of patients for economic reasons, so their evaluation must be highly transparent. OBJECTIVE To assess the quality of reporting of bioequivalence trials comparing generic to brand-name drugs. METHODOLOGY/PRINCIPAL FINDINGS PubMed was searched for reports of bioequivalence trials comparing generic to brand-name drugs between January 2005 and Decem...

2017
Vybhav Jetty Charles J Glueck Kevin Lee Naila Goldenberg Marloe Prince Ashwin Kumar Michael Goldenberg Ishan Anand Ping Wang

BACKGROUND Proprotein convertase subtilisin/kexin type 9 inhibitors, Praluent (alirocumab [ALI]) and Repatha (evolocumab [EVO]) have been approved as adjuncts to the standard-of-care maximal-tolerated dose (MTD) of low-density lipoprotein cholesterol (LDLC)-lowering therapy (LLT), statin therapy, in heterozygous (HeFH) (ALI or EVO) or homozygous (EVO) familial hypercholesterolemia, or clinical ...

2002
D van der Heijde J Braun D McGonagle J Siegel

Emerging treatment options in ankylosing spondylitis (AS) are giving new hope to patients with this chronic and potentially disabling disease. Clinical development of new treatments requires that rigorous and well controlled trials be conducted to demonstrate safety and efficacy. A number of classification systems have been developed in recent years as a result of enhanced understanding of the ...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید